Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Deloitte's 2026 Life Sciences and Health Care Outlook projects that U.S. health systems and biopharma companies could lose a combined $168 billion over the next decade if they fail to adapt to consumer expectations for convenience, affordability, and trust.
Therap Services has launched Therap AI, a suite of artificial intelligence tools designed to improve documentation efficiency and accuracy for human services providers. The tools include features such as automated quality assurance, facial recognition attendance, and secure data summarization.
Sectra will deliver its Sectra One Cloud enterprise imaging solution to an 11-site healthcare system in the southeastern United States under a $45.6 million contract, providing managed radiology and breast imaging services.
Hyland and Tribun Health have announced a partnership to integrate their technologies, creating an AI-driven digital pathology solution aimed at improving diagnostic workflows and collaboration in healthcare settings worldwide.
Lightbeam Health Solutions and Wakely Consulting Group have introduced two new tools, ACO Optimization Retrosight and ACO Optimization Futuresight, designed to help Accountable Care Organizations enhance network performance and forecast outcomes.
Deloitte released its 2025 North America Technology Fast 500 rankings, naming AI healthcare company Impiricus as the fastest-growing business with a 29,738% revenue increase from 2021 to 2024.
OpenAI has led a $15 million seed funding round for Red Queen Bio, a startup spun out of Helix Nano that uses AI and lab research to prevent AI-enabled biological threats. The investment was approved by OpenAI's compliance team and unconflicted board members.
A new report by MIT Technology Review Insights and Globant finds that nearly three quarters of global pharmaceutical organizations are piloting or deploying agentic AI, with top use cases in compliance, data integration, and patient support.
Diversis Capital has merged Genesis Automation Healthcare, Kermit, and Meperia into a unified entity under the Genesis Automation Healthcare brand, creating an AI-enabled platform for hospital supply chain and inventory management.
The second annual Universal 'AI for Health' Summit, organized by AI CoLab, brought together healthcare leaders, educators, and researchers in Washington to discuss practical AI applications in healthcare, according to a press release. The event featured panels on topics including conversational AI, predictive modeling, and governance frameworks.
SOPHiA GENETICS and Element Biosciences announced a partnership to combine AI analytics with sequencing technology, creating an end-to-end workflow for next-generation sequencing in precision medicine research.
At the Future of Health Summit in Los Angeles, more than 65 global health leaders unveiled a roadmap to transform healthcare systems, focusing on AI integration, primary care, and chronic disease management.
CereCore has joined Oracle's enhanced partner program to strengthen its support for healthcare organizations using Oracle Health platforms. The partnership enables CereCore to expand its capabilities in application management, optimization, and IT infrastructure services.
Supreme Group has appointed Olly Johnston as Executive Vice President of Platform Growth and Transformation to lead strategic initiatives across healthcare and life sciences marketing.
Conexiant has launched MDspire, an AI-powered platform that curates and synthesizes medical information for physicians and researchers, combining retrieval-augmented generation with expert review to ensure accuracy.
PureHealth reported AED 20.1 billion in revenue and AED 1.55 billion in net profit for the first nine months of 2025, reflecting growth across its healthcare and insurance operations.
A new report from Silicon Valley Bank reveals that AI-enabled provider operations have attracted the majority of Healthtech investment in 2025, accounting for 44% of total funding and 73% of mega-deals.
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
GT Biopharma, IDEAYA Biosciences, Zymeworks, and Regeneron Pharmaceuticals have each reported progress in oncology trials and approvals, highlighting continued momentum in biomarker-driven cancer treatments.
The Critical Path Institute has launched the Critical Path Disease Modeling Coalition to develop regulatory-grade models for pediatric inflammatory bowel disease, starting from its European hub.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
